BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10825600)

  • 1. Successful DNA immunisation of rats against fasciolosis.
    Kofta W; Mieszczanek J; Płucienniczak G; Wedrychowicz H
    Vaccine; 2000 Jul; 18(26):2985-90. PubMed ID: 10825600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune response of rats to vaccination with the cDNA or protein forms of the cysteine proteinase of Fasciola hepatica.
    Wedrychowicz H; Lamparska M; Kesik M; Kotomski G; Mieszczanek J; Jedlina-Panasiuk L; Płucienniczak A
    Vet Immunol Immunopathol; 2003 Jul; 94(1-2):83-93. PubMed ID: 12842614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.
    Kesik-Brodacka M; Lipiec A; Kozak Ljunggren M; Jedlina L; Miedzinska K; Mikolajczak M; Plucienniczak A; Legocki AB; Wedrychowicz H
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005451. PubMed ID: 28333957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses in rats and sheep induced by a DNA vaccine containing the phosphoglycerate kinase gene of Fasciola hepatica and liver fluke infection.
    Wesołowska A; Zawistowska-Deniziak A; Norbury LJ; Wilkowski P; Januszkiewicz K; Pyziel AM; Zygner W; Wędrychowicz H
    Acta Parasitol; 2016 Mar; 61(2):212-20. PubMed ID: 27078643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
    Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
    Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the immune response of male and female rats vaccinated with cDNA encoding a cysteine proteinase of Fasciola hepatica (FhPcW1).
    Wesołowska A; Norbury LJ; Januszkiewicz K; Jedlina L; Jaros S; Zawistowska-Deniziak A; Zygner W; Wędrychowicz H
    Acta Parasitol; 2013 Jun; 58(2):198-206. PubMed ID: 23666656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mucin-like peptide from Fasciola hepatica induces parasite-specific Th1-type cell immunity.
    Noya V; Brossard N; Berasaín P; Rodríguez E; Chiale C; Mazal D; Carmona C; Freire T
    Parasitol Res; 2016 Mar; 115(3):1053-63. PubMed ID: 26637311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of liver fluke DNA vaccines: A systematic review and meta-analysis: Guiding novel vaccine development.
    Jayaraj R; Kumarasamy C; Norbury L; Piedrafita D; Smooker P
    Vet Parasitol; 2019 Mar; 267():90-98. PubMed ID: 30878093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica.
    Mulcahy G; O'Connor F; McGonigle S; Dowd A; Clery DG; Andrews SJ; Dalton JP
    Vaccine; 1998; 16(9-10):932-9. PubMed ID: 9682340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
    Garza-Cuartero L; Geurden T; Mahan SM; Hardham JM; Dalton JP; Mulcahy G
    Vaccine; 2018 Feb; 36(7):958-968. PubMed ID: 29373193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood leukocyte responses in rats vaccinated with cDNA encoding glutathioinie-S-transferase of Fasciola hepatica.
    Wedrychowicz I; Jedlina-Panasiuk L; Szymanski P; Bieńkowska-Szewczyk K
    Wiad Parazytol; 2001; 47(4):551-7. PubMed ID: 16886389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes.
    Rojas-Caraballo J; López-Abán J; Pérez del Villar L; Vizcaíno C; Vicente B; Fernández-Soto P; del Olmo E; Patarroyo MA; Muro A
    PLoS One; 2014; 9(8):e105323. PubMed ID: 25122166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
    Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
    Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses of cattle to experimental anti-Fasciola hepatica vaccines.
    Mulcahy G; O'Connor F; Clery D; Hogan SF; Dowd AJ; Andrews SJ; Dalton JP
    Res Vet Sci; 1999 Aug; 67(1):27-33. PubMed ID: 10425237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the humoral immune response in alpacas (Lama pacos) experimentally infected with Fasciola hepatica against cysteine proteinases Fas1 and Fas2 and histopathological findings.
    Timoteo O; Maco V; Maco V; Neyra V; Yi PJ; Leguía G; Espinoza JR
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):77-86. PubMed ID: 15910994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
    Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
    Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
    Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
    J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1).
    Kesik M; Jedlina-Panasiuk L; Kozak-Cieszczyk M; Płucienniczak A; Wedrychowicz H
    Vaccine; 2007 May; 25(18):3619-28. PubMed ID: 17289224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasciola hepatica leucine aminopeptidase, a promising candidate for vaccination against ruminant fasciolosis.
    Acosta D; Cancela M; Piacenza L; Roche L; Carmona C; Tort JF
    Mol Biochem Parasitol; 2008 Mar; 158(1):52-64. PubMed ID: 18178266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: identification of genes and pathways involved in conferring immunoprotection in a murine model.
    Rojas-Caraballo J; López-Abán J; Moreno-Pérez DA; Vicente B; Fernández-Soto P; Del Olmo E; Patarroyo MA; Muro A
    BMC Infect Dis; 2017 Jan; 17(1):94. PubMed ID: 28114888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.